Skip to content

HUB Organoids

services
technology
company
- about us
- careers
- events
- latest news
resources
license program
contact

Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation

J Cyst Fibros | Sep 2021 | Clinical trial

Contact Careers Privacy Policy

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

X

Have any questions?

contact us